Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
The most frequent disorder of glycosylation is due to mutations in the gene encoding phosphomannomutase2 (PMM2-CDG). For this disease, which is autosomal and recessive, there is no cure at present. Most patients are composite heterozygous and carry one allele encoding an inactive mutant, R141H, and...
Main Authors: | Andreotti, Giuseppina, Monti, Maria Chiara, Citro, Valentina, Cubellis, Maria Vittoria |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619449/ |
Similar Items
-
Conformational Response to Ligand Binding in Phosphomannomutase2: INSIGHTS INTO INBORN GLYCOSYLATION DISORDER*
by: Andreotti, Giuseppina, et al.
Published: (2014) -
Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
by: Andreotti, Giuseppina, et al.
Published: (2013) -
A thermodynamic assay to test pharmacological chaperones for Fabry disease☆
by: Andreotti, Giuseppina, et al.
Published: (2014) -
Drug repositioning can accelerate discovery of pharmacological chaperones
by: Hay Mele, Bruno, et al.
Published: (2015) -
The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
by: Valentina Citro, et al.
Published: (2018-07-01)